ro glp 1 Launches GLP-1 Insurance Coverage Checker Get access to GLP-1 medication—prescribed

If calcitonin testing is performed for clinical reasons and results are elevated, confirmation with repeat testing is advisable

Just two weeks later, on 1 April 2026, the FDA approved Foundayo, Eli Lillys brand name for orforglipron, making it the first small-molecule, non-peptide oral GLP-1 receptor agonist approved for chronic weight management

Farxiga is an SGLT2 inhibitor an oral medication that lowers blood glucose levels by blocking glucose reabsorption in the kidneys, causing sugar to be eliminated through urine

Exogenous glucagon-like peptide 1 reduces contractions in human colon circular muscle

Heres what we know so far

If a patient successfully lost the desired amount of weight and feels confident they can stick to the diet and exercise plan, they may begin to taper off the medication